BioDirection

BioDirection is a medical device company dedicated to developing advanced and rapid point-of-care products for the objective diagnosis and management of concussions and other traumatic brain injuries (TBI).The company's first product is called the Tbit System. The Tbit System is the world's first multiplexing platform that utilizes patented biosensing nanowire technology, capable of detecting and measuring very low concentrations of "biomarker" proteins released from the brain after a concussion or other traumatic brain injury, accurately confirming a concussion in less than 90 seconds.